What is PTD-DBM?
PTD-DBM is a peptide that interferes with CXXC5, a negative regulator of the Wnt pathway. It gained attention from research out of South Korea suggesting it could promote hair regeneration by re-activating Wnt/β-catenin signaling in the follicle. The key honest point: this is early, largely preclinical research, and human evidence is very limited.1
Benefits & what it’s studied for
Preclinical research suggests follicle reactivation; human data is minimal.
This is genuinely research-stage, and marketing claims run well ahead of the evidence.
How does PTD-DBM work?
PTD-DBM is proposed to block CXXC5’s inhibition of the Wnt/β-catenin pathway, which plays a role in hair-follicle regeneration. This mechanism is interesting but not established in robust human trials.3
Dosing & administration
Discussed as a topical application in research contexts.4 This is educational, not medical advice. Any use and formulation should be guided by a licensed provider.
Risks, side effects & safety
Human safety data is essentially absent for routine use; this is a research-stage compound. Medical guidance is important.5
Legality & status
PTD-DBM is a research-stage peptide, not FDA-approved, and not among the peptides in the April 2026 Category 2 removals or PCAC dockets. Sourcing and quality vary widely and it’s largely sold “research use only.” Off Category 2 ≠ 503A-compoundable ≠ FDA-approved. Confirm with a licensed provider.6 See the full picture in our legality explainer.
Regulatory status as of June 2026 — reconfirm against the live FDA 503A list before go-live.
Thinking about PTD-DBM?
Talk to a licensed provider who can tell you if it fits your goals — and build a safe protocol.
Research & references
- 1Korean hair-regeneration research — PTD-DBM / CXXC5 / Wnt. Link to be finalized. link pending
- 2Preclinical (mouse) follicle-reactivation data. Link to be finalized. link pending
- 3Mechanism — CXXC5 inhibition of Wnt/β-catenin (flagged limited). Link to be finalized. link pending
- 4Research topical-use context (with valproic acid). Link to be finalized. link pending
- 5Safety — essentially no human routine-use data. Link to be finalized. link pending
- 6FDA status — research-only; not approved; not on PCAC dockets. Confirm at publish. link pending
Reference links are illustrative placeholders — replace with verified PubMed/journal URLs before publishing.
Frequently asked questions
What is PTD-DBM used for?+
It’s studied (mostly preclinically) for hair regeneration via the Wnt signaling pathway.
Does PTD-DBM regrow hair in humans?+
The promising results are largely from mouse studies; human evidence is very limited, so we grade it Limited.
Is PTD-DBM FDA-approved?+
No. It’s a research-stage compound, often sold ‘research use only.’ Confirm status with a provider.
How is PTD-DBM used?+
Discussed as a topical in research; any use should be guided by a provider.
Is PTD-DBM safe?+
Human safety data is essentially absent for routine use — a key reason for caution and the Limited grade.